Prognose
Für dieses Unternehmen liegen uns keine Analysten-Daten vor.
Scoring-Modelle
Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.
Beliebteste Broker
News
14.09. - 11:00 Uhr
Latest VIVIS LOI Potential First Step to Phase 1 Clinical Trial on Preventing COVID-19 Infections Using CBD
KATY, TX / ACCESSWIRE / September 14, 2021 / Neutra Corp. subsidiary VIVIS has signed a groundbreaking letter of intent (LOI) with a Houston clinical research company that, if it comes to a successful conclusion, would lead to testing hemp-based cannabinoids to treat COVD-19. Under the LOI's provisions, VIVIS will now determine the feasibility of working with Mercury Clinical Research to start phase 1 clinical trial on CBD efficacies in combating SARS-COVID-2. » Mehr auf accesswire.com
13.09. - 11:00 Uhr
Latest VIVIS LOI Potential First Step to Phase 1 Clinical Trial on Preventing COVID-19 Infections Using CBD
KATY, TX / ACCESSWIRE / September 13, 2021 / Neutra Corp. subsidiary VIVIS has signed a groundbreaking letter of intent (LOI) with a Houston clinical research company that, if it comes to a successful conclusion, would lead to testing hemp-based cannabinoids to treat COVID-19. Under the LOI's provisions, VIVIS will now determine the feasibility of working with Mercury Clinical Research to start phase 1 clinical trial on CBD efficacies in combating SARS-COVID-2. » Mehr auf accesswire.com
16.08. - 11:00 Uhr
Neutra Corp. Provides Strategic Update
KATY, TX / ACCESSWIRE / August 16, 2021 / Neutra Corp. (OTC PINK:NTRR) continues to make substantial progress in securing distribution for its wholly-owned subsidiary VIVIS' CBD products. Since announcing this strategy in January, Neutra management has successfully placed VIVIS in Festival Foods, a large 35 store regional supermarket chain. » Mehr auf accesswire.com
Unternehmenszahlen
| (EUR) | Juli 2023 | |
|---|---|---|
| Umsatz | 3,93k | 86,17% |
| Bruttoeinkommen | 1,53k | 90,57% |
| Nettoeinkommen | 65,33k | 31,56% |
| EBITDA | 53,40k | 12,96% |
Fundamentaldaten
| Metrik | Wert |
|---|---|
Marktkapitalisierung | 797,77k € |
Anzahl Aktien | 2,92 Mrd |
52 Wochen-Hoch/Tief | 0,000729 € - 0,000182 € |
| Dividenden | Nein |
Beta | 2,92 |
KGV (PE Ratio) | 1,75 |
KGWV (PEG Ratio) | 0,0175 |
KBV (PB Ratio) | 0,99 |
KUV (PS Ratio) | 22,18 |
Unternehmensprofil
Neutra Corp. erforscht, entwickelt und liefert nutrazeutische Produkte auf Hanfbasis. Es bietet CBD-Sportcremes und andere Produkte an. Das Unternehmen wurde im Jahr 2011 gegründet und hat seinen Sitz in Sugar Land, Texas.
| Name | Neutra Corp. |
| CEO | Sydney Jim |
| Sitz | Sugar Land,
tx USA |
| Website | |
| Industrie | Körperpflegeprodukte |
| Börsengang | 12.10.2011 |
| Mitarbeiter | 15 |
Ticker Symbole
| Börse | Symbol |
|---|---|
Pnk | NTRR |
Otc | NTRR |
Assets entdecken
Shareholder von Neutra Corp. investieren auch in folgende Assets
